Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Starbucks
SBUX
|
+$818M |
| 2 |
Constellation Energy
CEG
|
+$695M |
| 3 |
Spotify
SPOT
|
+$694M |
| 4 |
CAVA Group
CAVA
|
+$523M |
| 5 |
Nike
NKE
|
+$509M |
Top Sells
| 1 |
Eaton
ETN
|
+$1.17B |
| 2 |
Microsoft
MSFT
|
+$987M |
| 3 |
Palo Alto Networks
PANW
|
+$978M |
| 4 |
Advanced Micro Devices
AMD
|
+$935M |
| 5 |
NVIDIA
NVDA
|
+$854M |
Sector Composition
| 1 | Technology | 32.76% |
| 2 | Communication Services | 17.2% |
| 3 | Consumer Discretionary | 15.67% |
| 4 | Healthcare | 10.6% |
| 5 | Financials | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Apogee Therapeutics
APGE
$2.2B
| $11M | 0.01% |
293,757
-18,634
| -6% | -$696K |
|
377
California Resources
CRC
$4.44B
| $10.7M | 0.01% |
242,343
+27,907
| +13% | +$1.23M |
|
378
Inspire Medical Systems
INSP
$2.37B
| $10.6M | 0.01% |
66,602
+19,016
| +40% | +$3.03M |
|
379
Wolverine World Wide
WWW
$2.48B
| $10.3M | 0.01% |
739,359
+147,215
| +25% | +$2.05M |
|
380
Microchip Technology
MCHP
$34.9B
| $10.1M | 0.01% |
208,416
+5,249
| +3% | +$254K |
|
381
nCino
NCNO
$3.48B
| $9.93M | 0.01% |
361,557
-211,535
| -37% | -$5.81M |
|
|
MTSR
382
Metsera, Inc. Common Stock
MTSR
$3.75B
| $9.68M | 0.01% |
+355,567
| New | +$9.68M |
|
383
Sanofi
SNY
$115B
| $9.32M | 0.01% |
168,103
-32,135
| -16% | -$1.78M |
|
384
CoStar Group
CSGP
$36.8B
| $9.28M | 0.01% |
117,183
-236,755
| -67% | -$18.8M |
|
385
Marcus & Millichap
MMI
$1.26B
| $9.07M | 0.01% |
263,182
-1,253
| -0.5% | -$43.2K |
|
386
Stantec
STN
$12.6B
| $9.04M | 0.01% |
108,992
+5,688
| +6% | +$472K |
|
|
SION
387
Sionna Therapeutics, Inc. Common Stock
SION
$1.01B
| $8.99M | 0.01% |
+859,927
| New | +$8.99M |
|
388
IDEAYA Biosciences
IDYA
$2.16B
| $8.63M | 0.01% |
526,688
-447,948
| -46% | -$7.34M |
|
389
MasTec
MTZ
$15B
| $8.6M | 0.01% |
73,672
+19,636
| +36% | +$2.29M |
|
390
Alamos Gold
AGI
$13.9B
| $8.44M | 0.01% |
+315,551
| New | +$8.44M |
|
391
Expro
XPRO
$1.43B
| $8.3M | 0.01% |
835,309
-1,447,209
| -63% | -$14.4M |
|
392
Elanco Animal Health
ELAN
$9.21B
| $8.05M | 0.01% |
766,595
-329,115
| -30% | -$3.46M |
|
393
Concrete Pumping Holdings
BBCP
$364M
| $7.69M | 0.01% |
1,407,713
-315,041
| -18% | -$1.72M |
|
394
Littelfuse
LFUS
$6.54B
| $7.28M | 0.01% |
37,015
-144,076
| -80% | -$28.3M |
|
395
BCE
BCE
$22.5B
| $7.18M | 0.01% |
312,532
| – | – |
|
396
RadNet
RDNT
$5.69B
| $7.07M | 0.01% |
142,107
+127,557
| +877% | +$6.34M |
|
397
Vale
VALE
$45.5B
| $7.05M | ﹤0.01% |
706,538
+317,150
| +81% | +$3.17M |
|
|
FL
398
DELISTED
Foot Locker
FL
| $7.05M | ﹤0.01% |
500,073
-140,278
| -22% | -$1.98M |
|
399
Synopsys
SNPS
$79B
| $6.48M | ﹤0.01% |
15,100
+1,313
| +10% | +$563K |
|
400
ASML
ASML
$320B
| $6.31M | ﹤0.01% |
9,516
+5,612
| +144% | +$3.72M |
|